Stockreport

CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF CorMedix (NasdaqGM:CRMD) plans to host an analyst day focused on updates to its clinical programs. The event will cover late stage data and plans for the REZZAYO and [Read more]